Utah Gets Money From Anxiety Drug [Buspar] Settlement
posted Monday, 24 January 2005
Attorney General Mark Shurtleff announced today that the state of Utah is receiving $565,000 from a settlement with the manufacturer of the anti-anxiety drug BuSpar. Bristol-Myers Squibb paid over $41 million to settle a multi-state antitrust lawsuit for allegedly making false statements to the Food & Drug Administration and conspiring to keep generic drugs from entering the marketplace.
Last July the drug manufacturer also sent $177,314 to 305 individual Utahns, which means the state of Utah and its citizens received a total of $742,506.
"Thanks to the dedicated lawyers of this office, consumers have been made whole and the state of Utah is no longer suffering the consequences of a company that illegally inflated drug prices," says Shurtleff.
Here's the breakdown of where the money will go:
- $11,017 University of Utah Medical Plan
- $275,084 Utah Medicaid Office
- $5,473 Utah Developmental Center
- $24,110 Utah State Hospital
- $60,025 Public Employees Health Program
- $189,483 Attorney General Antitrust Litigation Fund
___________________
$565,192 Total
The settlement covered individuals and organizations that purchased BuSpar between 1998 and 2003 and filed valid claims by December 5, 2003. Assistants Attorney General Ronald Ockey and James Palmer represented Utah in the settlement. The suit was filed in 2001 against Bristol-Myers Squibb Co., Watson Pharma, Inc. and Danbury Pharmacal, Inc. and settled two years later.
Full text: http://attorneygeneral.utah.gov/PrRel/prjan212005.htm
links: digg this del.icio.us technorati reddit